EVEROLIMUS (Certican®)

Clinical Indication

Immunosuppressive therapy for Kidney Transplant in Adults and Children/Young People

Comments

In line with NICE TA 481, NICE TA 482

Date of classification

January 2018

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.